Player FM - Internet Radio Done Right
Checked 6d ago
जोड़े गए eight सालो पहले
Taylor & Francis Group and Francis Group द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Taylor & Francis Group and Francis Group या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Player FM - पॉडकास्ट ऐप
Player FM ऐप के साथ ऑफ़लाइन जाएं!
Player FM ऐप के साथ ऑफ़लाइन जाएं!
Future Science Group
सभी (नहीं) चलाए गए चिह्नित करें ...
Manage series 1258384
Taylor & Francis Group and Francis Group द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Taylor & Francis Group and Francis Group या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Podcast by Taylor & Francis Group
…
continue reading
288 एपिसोडस
सभी (नहीं) चलाए गए चिह्नित करें ...
Manage series 1258384
Taylor & Francis Group and Francis Group द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Taylor & Francis Group and Francis Group या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Podcast by Taylor & Francis Group
…
continue reading
288 एपिसोडस
सभी एपिसोड
×F
Future Science Group

1 Cell therapies for autoimmune diseases: a podcast with Lindsay Davies 13:17
13:17
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद13:17
This International Women’s Day, we’re joined by Lindsay Davies, Chief Scientific Officer at NextCell Pharma (Stockholm, Sweden), to discuss the evolving role of cell therapies in treating autoimmune diseases. In this podcast, Davies breaks down the science behind NextCell’s mesenchymal stromal cell therapy for type 1 diabetes and explores how these cells could be applied to other autoimmune conditions. She emphasizes the importance of tailoring cell therapies based on disease type, stage and patient profile to achieve the best outcomes. The conversation also highlights how growing evidence of sex-related differences will could increasingly shape decisions in the development and testing of cell therapies.…
F
Future Science Group

1 The use of GenAI in bioanalysis: an interview with Priyata Kalra 28:30
28:30
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद28:30
During the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 2024 conference, Bioanalysis Zone caught up with industry experts across numerous disciplines to discuss their involvement with AAPS and their research. In this interview, we spoke to Priyata Kalra about her talk on the use of GenAI within biomedicine.…
F
Future Science Group

1 The need for HRMS for quantitation of ADCs vs. QQQ: an interview with Megan Cooley 21:35
21:35
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद21:35
In this episode, we sit down with Megan Cooley, Associate Director of Bioanalytical Services at ICON (KS, USA), to explore the cutting-edge world of antibody-drug conjugate (ADC) quantitation using high-resolution mass spectrometry (HRMS). Megan delves into the capabilities of Triple Quadrupole and Time-of-Flight mass spectrometry, offering her expert insights into whether HRMS is essential for ADC PK studies. We also tackle the challenges and limitations of HRMS in ADC quantitation and discuss the potential for AI to create more specific and stable ADCs. Finally, Megan highlights ICON’s extensive experience with large molecule applications and their innovative approach to supporting complex LC–MS analyses.…
F
Future Science Group

1 How can medical device regulation catch up with innovation? 12:36
12:36
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद12:36
In this interview, we discuss the potential of AI in increasing healthcare system efficiency, how medical devices are making procedures less invasive and what those working in the field of medical devices can do to help regulation catch up with innovation.
F
Future Science Group

1 The new frontier: assessing efficacy and safety of CGTs using biomarkers 24:21
24:21
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद24:21
In the sixth episode of The new frontier podcast, we're joined by Catherine Vrentas, Life Sciences Lead at Booz Allen Hamilton (VA, USA). Cathy explains how biomarkers can be used to predict the therapeutic outcome and efficacy of CGTs and the biomarkers in particular that have shown strong predictive value. We delve into the common challenges of working with biomarkers in CGTs and how biomarker kits can be adapted for CGT work.…
F
Future Science Group

Carlon Fitzpatrick AI Summit by Taylor & Francis Group
F
Future Science Group

1 Challenges and solutions in monitoring assay performance for vaccine development 18:26
18:26
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद18:26
Challenges and solutions in monitoring assay performance for vaccine development: an interview with Atul Chaudhari
F
Future Science Group

1 ADA detection and characterization for immunogenicity testing: insights from ICON's Lindsay Denhoff 11:13
11:13
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद11:13
We caught up with Principal Scientist Lindsay Denhoff (ICON; Dublin, Ireland) to discuss immunogenicity considerations for therapeutic proteins and the current analytical methodologies for detecting and characterizing anti-drug antibodies (ADAs). Lindsay shares some industry best practices for achieving high-quality ADA assays, as well as some of the advantages and limitations of singlicate ADA analysis compared with alternative techniques. We finish the interview with a look to the future where Lindsay discusses the emerging trends she's spotted in the field of immunogenicity and offers her predictions for how they may shape the future of therapeutic protein development.…
F
Future Science Group

In this Tech Blast episode supported by Sartorius (Göttingen, Germany), we speak with David Apiyo – Manager of Applications Development at Sartorius (MN, USA) – about epitope binning, why it's performed and the best ways to conduct it. Plus, learn more about Sartorius' biolayer interferometry platforms and their application in epitope binning.…
F
Future Science Group

1 Using the Gyrolab® platform for oligo quantification: an interview with John Chappell 6:35
6:35
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद6:35
In this interview, we spoke to John Chappell, Senior Global Scientific Support Manager at Gyros Protein Technologies (Uppsala, Sweden) about his experience working with the Gyrolab platform for oligonucleotide assays. John discusses the advantages of using Gyrolab for oligo quantification in biological fluids and shares his thoughts on the next steps for these assays.…
F
Future Science Group

1 The new frontier: qPCR vs ddPCR for cell and gene therapies 15:41
15:41
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद15:41
In the fifth episode of The New Frontier podcast, we're joined by Paul Byrne, Senior Director of Genomics from ProtaGene (MA, USA). Paul describes his experience working with qPCR vs digital and digital droplet PCR assays and advises on their pros and cons, as well as when it's best to use each. We discuss how these assays can be optimized for cell and gene therapy targets and get a peek into the tips and tricks he's picked up over his 30 years of experience.…
F
Future Science Group

1 The new frontier: using LC–MS/MS for quantitative assays to support gene therapies 13:33
13:33
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद13:33
In this episode of The New Frontier podcast, we're joined by Daniel Schulz-Jander, Senior Director of Mass spectrometry Bioanalysis at QPS Netherlands (Groningen). Daniel explains how he uses immune-precipitation and immunoaffinity LC–MS techniques for his work relating to macromolecular pharmaceuticals like gene therapies, as well as their benefits and challenges. Daniel also covers bottom-up, middle-down and top-down approaches and their suitability for his work in clinical support versus research and discovery.…
F
Future Science Group

1 Breaking down barriers for women in tech: an interview with Tina Marshall 16:15
16:15
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद16:15
Breaking down barriers for women in tech: an interview with Tina Marshall by Taylor & Francis Group
F
Future Science Group

1 Uncovering the link between cancer disparities and climate change 14:35
14:35
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद14:35
What disparities exist in cancer screening and how does this impact patient outcomes? Listen to our latest podcast episode with Kilan Ashad-Bishop (American Cancer Society) to find out about the intersection between science, health, and society.
F
Future Science Group

1 AI-driven early disease detection: an interview with Jim Kean 28:19
28:19
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद28:19
AI-driven early disease detection: an interview with Jim Kean by Taylor & Francis Group
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।